Canada markets closed

Panbela Therapeutics, Inc. (PBLA)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.4100-0.0300 (-6.82%)
At close: 03:27PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
20,614
20,614
28,049
5,423
2,505
Selling General and Administrative
5,033
5,033
6,044
4,587
3,249
Total Operating Expenses
25,647
25,647
34,093
10,010
5,754
Operating Income or Loss
-25,647
-25,647
-34,093
-10,010
-5,754
Interest Expense
317
317
288
12
17
Total Other Income/Expenses Net
392
392
-682
-602
708
Income Before Tax
-25,449
-25,449
-35,049
-10,623
-5,063
Income Tax Expense
-186
-186
-116
-488
-295
Income from Continuing Operations
-25,263
-25,263
-34,933
-10,135
-4,768
Net Income
-25,263
-25,263
-34,933
-10,135
-4,768
Net Income available to common shareholders
-25,263
-25,263
-34,933
-10,135
-4,768
Basic EPS
-157.02
-316.52
-19.97k
-18.10k
-11.86k
Diluted EPS
-157.02
-316.52
-19.97k
-18.10k
-11.86k
Basic Average Shares
149.816
108.691
1.749
0.56
0.402
Diluted Average Shares
149.816
108.691
1.749
0.56
0.402